
    
      This is a multicenter, randomized, double-blind, active comparator, parallel two arm study to
      compare the efficacy, and to evaluate the safety, and immunogenicity of BAT1406 to Humira® in
      patients with active ankylosing spondylitis (AS) to demonstrate clinical equivalence of
      BAT1406 and Humira®.
    
  